Filter by: Subject

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (72)
Human immunodeficiency virus (HIV) (60)
South Africa (SA) (51)
COVID-19 pandemic (29)
Coronavirus disease 2019 (COVID-19) (28)
Antiretroviral therapy (ART) (21)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (21)
Health sciences article SDG-03 (18)
Treatment (17)
Streptococcus pneumoniae (16)
Mesenchymal stromal/stem cells (MSCs) (14)
Patients (14)
Pneumococcus (14)
Tuberculosis (TB) (14)
Platelets (13)
Neutrophils (12)
Community-acquired pneumonia (CAP) (11)
Inflammation (10)
Mortality (10)
Biomarkers (9)
Children (9)
Cytokines (9)
Pneumolysin (9)
Cancer (8)
HIV-1 (8)
Infection (8)
Reactive oxygen species (8)
Breast cancer (7)
Gene therapy (7)
Immunotherapy (7)
Macrolides (7)
South Africa (7)
Africa (6)
Immunosuppression (6)
In vivo (6)
Lung cancer (6)
Mycobacterium tuberculosis (MTB) (6)
People living with HIV (PLHIV) (6)
Vaccine (6)
Angiogenesis (5)
Chemotherapy (5)
Corticosteroids (5)
Disease (5)
Drug resistance (5)
Ethics (5)
Febrile neutropenia (5)
Human leukocyte antigen (HLA) (5)
Immune activation (5)
Immune dysregulation (5)
In vitro (5)
Low- and middle-income countries (LMICs) (5)
Luteinizing hormone (LH) (5)
Obesity (5)
Rheumatoid arthritis (RA) (5)
Smoking (5)
Acquired immune deficiency syndrome (AIDS) (4)
Adipose tissue (4)
Antibiotics (4)
Calcium (4)
Cell therapy (4)
Community-acquired pneumonia (4)
Deoxyribonucleic acid (DNA) (4)
Diagnosis (4)
Growth (4)
Hydrogen peroxide (4)
Immune checkpoint inhibitor (ICI) (4)
Immune checkpoint inhibitors (4)
Immune system (4)
Informed consent (4)
Kisspeptin (4)
Macrophages (4)
Microbial translocation (4)
Nausea (4)
Nivolumab (4)
Oxytocin (4)
Pharmacogenetics (4)
Pneumonia (4)
Stem cells (4)
Toll-like receptors (4)
Vaccination (4)